- Home
- ATRA vs FBRX Comparison
ATRA vs FBRX Comparison
Compare ATRA & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- FBRX
- Stock Information
- Founded
- ATRA 2012
- FBRX N/A
- Country
- ATRA United States
- FBRX United States
- Employees
- ATRA N/A
- FBRX N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ATRA Health Care
- FBRX Health Care
- Exchange
- ATRA Nasdaq
- FBRX Nasdaq
- Market Cap
- ATRA 32.4M
- FBRX 35.3M
- IPO Year
- ATRA 2014
- FBRX N/A
- Fundamental
- Price
- ATRA $6.17
- FBRX $7.34
- Analyst Decision
- ATRA Buy
- FBRX Strong Buy
- Analyst Count
- ATRA 5
- FBRX 3
- Target Price
- ATRA $17.75
- FBRX $80.50
- AVG Volume (30 Days)
- ATRA 47.4K
- FBRX 50.8K
- Earning Date
- ATRA 05-08-2025
- FBRX 05-12-2025
- Dividend Yield
- ATRA N/A
- FBRX N/A
- EPS Growth
- ATRA N/A
- FBRX N/A
- EPS
- ATRA N/A
- FBRX N/A
- Revenue
- ATRA $128,940,000.00
- FBRX N/A
- Revenue This Year
- ATRA N/A
- FBRX N/A
- Revenue Next Year
- ATRA N/A
- FBRX N/A
- P/E Ratio
- ATRA N/A
- FBRX N/A
- Revenue Growth
- ATRA 1404.02
- FBRX N/A
- 52 Week Low
- ATRA $5.01
- FBRX $4.11
- 52 Week High
- ATRA $19.00
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- ATRA 47.91
- FBRX 52.55
- Support Level
- ATRA $5.16
- FBRX $5.25
- Resistance Level
- ATRA $6.11
- FBRX $6.43
- Average True Range (ATR)
- ATRA 0.61
- FBRX 0.82
- MACD
- ATRA 0.08
- FBRX 0.21
- Stochastic Oscillator
- ATRA 78.98
- FBRX 57.71
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).